Common antibiotic linked to risk of sudden death, study finds

Share this article:
An antibiotic frequently used to treat pneumonia and bronchitis is linked to a higher risk of sudden death in adults, particularly those with heart conditions, a new study reveals. 

Azithromycin, which is frequently referred to as a “Z-Pak,” was generally believed to be safer than antibiotics such as erythromycin and clarithromycin. Previous studies have linked erythromycin with a higher risk for heart attack. 

However, when researchers from Vanderbilt University calculated the rate of deaths per million courses of treatment, based on the medical records of about 540,000 Medicaid recipients, azithromycin had 64.6 deaths per million courses. Amoxicillin was much lower, with a rate of 21.8, according to the study.

Individuals with conditions such as heart failure, or who have undergone a bypass, are considered to be at a higher risk for death, the New York Times reported. 

The study was published May 17 in the New England Journal of Medicine.

Share this article:

More in News

Bulk of Medicaid to be managed care in two years: Avalere

Bulk of Medicaid to be managed care in ...

More than three-quarters of Medicaid beneficiaries will be enrolled in a managed care plan as of 2016, according to an Avalere Health analysis released Thursday. The numbers reveal that managed ...

Nursing home asked for employee's personal information too often, jury rules

The human resources department of a Maine nursing home did not properly protect a former employee's personal identification information, a jury recently ruled.

Test could confirm sepsis within an hour

Nursing home residents might benefit from a new way of diagnosing and treating sepsis made possible by discoveries out of the University of British Columbia.